Cytolytic activity against tumor cells by macrophage cell lines and augmentation by macrophage stimulants

International Journal of Cancer

Volumn 26, Issue 1, 1980, Pages 61-69

  Taniyama, Tadayoshi ^a   Holden, Howard T ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; POLYINOSINIC POLYCYTIDYLIC ACID; ZYMOSAN;

ANIMAL EXPERIMENT; CORYNEBACTERIUM PARVUM; CYTOLYSIS; IN VITRO STUDY; MACROPHAGE; MOUSE; TUMOR CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMAL; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; HUMAN; INTERFERONS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NEOPLASMS, EXPERIMENTAL; POLY I-C;

EID: 0018833383     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910260110     Document Type: Article

References (37)

1. Endotoxin and doublestranded RNA render macrophages cytotoxic
2. Isolation of a continuous epitheloid cell line, HBT‐3, from a human breast carcinoma
3. Cell‐mediated cytotoxicity, allograft rejection, and tumor immunity
4. Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells
5. Macrophage stimulation by bacterial lipopolysaccharides. II. Evidence for differentiation signals delivered by lipid A and by a protein‐rich fraction of lipopolysaccharides
6. 51Cr‐release cytotoxicity of lymphocyts immune to murine sarcoma virus
7. Natural cell‐mediated immunity
8. Modulation of the tumoricidal function of activated macrophages by bacterial endotoxin and mammarian macrophage activation factor(s)
9. Two functionally distinct anti‐tumor effector cells isolated from primary murine sarcoma virus‐induced tumors
10. Increased superoxide anion production by immunologically activated and chemically elicited macrophages
11. Identification of macrophage‐like characteristics in a cultured murine tumor line
12. Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages
13. Preparation of lymphocyte‐activating factor from continuous murine macrophage cell lines
14. Esterase in human leucocytes
15. Cytotoxicity of a factor isolated from human spleen
16. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides
17. Purification of mouse interferon by affinity‐chromatography on anti‐interferon globulin‐Sepharose
18. Effects of lipids and lymphokine on peritoneal and cell line macrophage lysis of RBC and tumor targets
19. Cytolytic and cytostatic antitumor activities of marcrophages from mice injected with murine sarcoma virus
20. Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines
21. Phagocytosis and cytolysis by a macrophage tumor and its cloned cell line
22. Antibody‐dependent killing of erythocyte and tumor targets by macrophage‐related cell lines: enhancement by PPD and LPS
23. Direct toxic effect of immunopotentiators on monocytic, myelomonocytic, and histiocytic or macrophage tumor cells in culture
24. Functional characterization of a stable. noncytolytic stage of macrophage activation in tumors
25. Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcoma
26. Functional and morphologic characteristics of interferon‐treated macrophages
27. Interferon: an inducer of macrophage activation by polyanion
28. Association of macrophage activation with antitumor activity by synthetic and biological agents
29. Natural occurrence of lymphocytes showing cytotoxic activity to BALB/c radiation‐induced leukemia Rlol cells
30. 1 and J774.1
31. Cytolytic activity of macrophages isolated from primary murine sarcoma virus (MSV)‐induced tumors
32. Direct augmentation of cytolytic activity of tumor‐derived macrophages and macrophage cell lines by muramyl dipeptide
33. Antibody‐dependent cytolysis of chicken erythrocytes by an in vitro‐established line of mouse peritoneal macrophages
34. Characterization of the effect of endotoxin on macrophage tumor cell killing
35. Activation of guinea pig macrophages by bacterial lipopolysaccharide requires bone‐marrow derived lymphocytes